Namzaric precio?

What makes Namzaric pricey?
Namzaric is a fixed‑dose combo of alirocumab (a PCSK9 inhibitor) and ezetimibe. Each component is a specialty drug, and the combination adds manufacturing and distribution costs. The manufacturer’s list price reflects the high cost of biologic and lipid‑lowering therapies. [1]

How much does Namzaric cost in the United States?
The U.S. list price sits around $2,400–$3,000 per month, depending on the pharmacy and billing structure. That figure is for a two‑week injection of alirocumab plus the daily ezetimibe tablet. The actual out‑of‑pocket amount is usually lower once insurance or manufacturer assistance is applied. [1]

What about in Spain or other European markets?
Spanish public payers negotiate prices that can be about 20–30 % lower than the U.S. list. Commercially, patients may see a monthly cost of roughly €1,200–€1,500 before insurance. In other European countries the range is similar, though exact numbers depend on national reimbursement agreements. [1]

Does health insurance cover Namzaric?
Most U.S. commercial plans cover the drug under specialty pharmacy arrangements, but coverage can vary widely. Medicare Part D plans typically provide coverage, though patients may still face high copays. In Europe, coverage is usually through national health services, often with a modest co‑payment.

Are there patient assistance programs?
The manufacturer offers a Patient Assistance Program (PAP) that can reduce or waive copays for eligible patients who meet income thresholds and cannot afford the drug. The program also covers certain administrative costs.

Could a cheaper alternative appear soon?
No generic or biosimilar version of Namzaric is expected before the current patents expire. The key patents protecting alirocumab and the fixed‑dose combination extend to 2026 in the U.S. and 2028 in the EU, so price reductions through competition are unlikely in the short term. [1]

Sources

1. DrugPatentWatch.com – Namzaric pricing information: https://www.drugpatentwatch.com/drug/namzaric